David Marek
Overview
David Marek received an average of $8M in total compensation, including $450K in salary, at Myovant Sciences Ltd. between 2020 and 2021. David Marek also received an average of $3M at Axsome Therapeutics between 2019 and 2020.
Source: SEC filings on July 27, 2022, April 23, 2021, and April 21, 2020.
Related executives
We found 14 more executives who work or worked at Myovant Sciences Ltd. and Axsome Therapeutics.
Herriot Tabuteau
Axsome Therapeutics
Chief Executive Officer
Uneek Mehra
Myovant Sciences Ltd.
Principal Financial Officer
Mark MA
Axsome Therapeutics
Chief Operating Officer
Frank Karbe
Myovant Sciences Ltd.
Former Principal Financial and Accounting Officer
Nick Pizzie
Axsome Therapeutics
Chief Financial Officer
Lauren Merendino
Myovant Sciences Ltd.
Chief Commercial Officer
Lynn Seely
Myovant Sciences Ltd.
Principal Executive Officer
Matthew Lang
Myovant Sciences Ltd.